{"product_id":"neuroclimax-advanced","title":"NeuroClimax™ Advanced – Nootropic Nasal Spray | 1-Month Supply","description":"\n\u003ch2\u003eNeuroClimax™ Advanced — A Forskolin and Noopept Intranasal Formulation\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eTwo principal compound groups. A distinct scientific approach. One proprietary NeuroClimax formulation.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eNeuroClimax™ Advanced\u003c\/strong\u003e is a proprietary intranasal nootropic formulation developed by \u003cstrong\u003eCNS Curative Technologies LLC\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003cp\u003eThe formulation features cyclic AMP (cAMP)-enhancing compounds, including forskolin, together with Noopept. These compounds have been investigated in scientific research involving neuronal signaling, neurotrophic pathways, synaptic plasticity, and mitochondrial biology.\u003c\/p\u003e\n\n\u003cp\u003eAdvanced differs from the NeuroClimax Gold formulations through its emphasis on cAMP-related signaling and its particular ingredient composition.\u003c\/p\u003e\n\n\u003cp\u003eThis product is presented as a one-month supply.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eScientific distinction:\u003c\/strong\u003e Research involving individual compounds and experimental formulations does not establish the clinical effectiveness or safety of the finished NeuroClimax Advanced product in humans.\u003c\/p\u003e\n\n\u003ch2\u003eWhat Makes NeuroClimax™ Advanced Different?\u003c\/h2\u003e\n\n\u003cp\u003eNeuroClimax Advanced brings together compounds with complementary scientific research backgrounds.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePrincipal active compounds:\u003c\/strong\u003e cAMP-enhancing compounds, including forskolin, and Noopept.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eScientific focus:\u003c\/strong\u003e Research involving cyclic AMP signaling, neuronal communication, and neurotrophic pathways.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDelivery format:\u003c\/strong\u003e Proprietary intranasal spray.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eProduct quantity:\u003c\/strong\u003e One-month supply.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation identity:\u003c\/strong\u003e Distinct from the kinetin-centered NeuroClimax Gold formulations.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDeveloper:\u003c\/strong\u003e CNS Curative Technologies LLC.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThe formulation reflects the company's research interests in biological processes associated with neuronal function.\u003c\/p\u003e\n\n\u003ch2\u003eUnderstanding the Active Ingredients\u003c\/h2\u003e\n\n\u003ch3\u003e1. Forskolin and Cyclic AMP-Enhancing Compounds\u003c\/h3\u003e\n\n\u003cp\u003eForskolin is a naturally occurring diterpene compound investigated for its ability to activate the enzyme adenylyl cyclase.\u003c\/p\u003e\n\n\u003cp\u003eAdenylyl cyclase participates in the production of \u003cstrong\u003ecyclic adenosine monophosphate (cAMP)\u003c\/strong\u003e, an intracellular signaling molecule involved in numerous biological processes.\u003c\/p\u003e\n\n\u003cp\u003eIn neuroscience research, cAMP-related signaling has been studied in connection with:\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eNeuronal communication and intracellular signaling.\u003c\/li\u003e\n\u003cli\u003eSynaptic plasticity.\u003c\/li\u003e\n\u003cli\u003eLearning and memory-related biological processes.\u003c\/li\u003e\n\u003cli\u003eCellular metabolism.\u003c\/li\u003e\n\u003cli\u003eNeurotrophic signaling.\u003c\/li\u003e\n\u003cli\u003eResponses to cellular stress.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThese biological relationships provide part of the scientific rationale for the development of NeuroClimax Advanced.\u003c\/p\u003e\n\n\u003cp\u003eHowever, the known biochemical activity of forskolin does not independently establish the effects of the finished intranasal formulation.\u003c\/p\u003e\n\n\u003ch3\u003e2. Noopept and Neurotrophic Signaling\u003c\/h3\u003e\n\n\u003cp\u003eNoopept is a synthetic nootropic compound investigated in experimental research involving neuronal function, learning, memory-related processes, and neurotrophic signaling.\u003c\/p\u003e\n\n\u003cp\u003ePreclinical investigations have examined its relationship with:\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eSynaptic communication.\u003c\/li\u003e\n\u003cli\u003eNeurotrophic signaling.\u003c\/li\u003e\n\u003cli\u003eGlutamatergic neurotransmission.\u003c\/li\u003e\n\u003cli\u003eNeuronal plasticity.\u003c\/li\u003e\n\u003cli\u003eLearning and memory-related biological mechanisms.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eSome experimental studies have investigated biological pathways involving \u003cstrong\u003ebrain-derived neurotrophic factor (BDNF)\u003c\/strong\u003e and \u003cstrong\u003enerve growth factor (NGF)\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003cp\u003eThese proteins participate in important processes associated with neuronal development, maintenance, and communication.\u003c\/p\u003e\n\n\u003cp\u003eThe research provides scientific context for Noopept but does not demonstrate that NeuroClimax Advanced improves cognitive performance in humans.\u003c\/p\u003e\n\n\u003ch2\u003eThe Scientific Foundation Behind NeuroClimax Advanced\u003c\/h2\u003e\n\n\u003ch3\u003ecAMP, BDNF, and NGF Signaling\u003c\/h3\u003e\n\n\u003cp\u003eNeuronal function depends on interconnected biological signaling pathways that regulate communication, cellular responses, and the maintenance of neural networks.\u003c\/p\u003e\n\n\u003cp\u003eThree important areas of neuroscience research relevant to the formulation are:\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCyclic AMP (cAMP):\u003c\/strong\u003e An intracellular signaling molecule involved in cellular communication and several neuronal signaling pathways.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBrain-Derived Neurotrophic Factor (BDNF):\u003c\/strong\u003e A protein involved in neuronal maintenance, development, and synaptic plasticity.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNerve Growth Factor (NGF):\u003c\/strong\u003e A neurotrophic factor involved in the development and maintenance of certain neuronal populations.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eResearch has examined relationships between these signaling systems and biological processes associated with neuronal survival, learning, and cellular responses to stress.\u003c\/p\u003e\n\n\u003cp\u003eThe development of NeuroClimax Advanced draws on this scientific background.\u003c\/p\u003e\n\n\u003ch3\u003eMitochondrial Function and Neuronal Biology\u003c\/h3\u003e\n\n\u003cp\u003eMitochondria participate in cellular energy production and other essential biological processes.\u003c\/p\u003e\n\n\u003cp\u003eScientific investigations have explored how mitochondrial function, oxidative stress, and neuronal signaling interact in healthy and experimental disease models.\u003c\/p\u003e\n\n\u003cp\u003eThese research areas contribute to the broader scientific foundation informing CNS Curative's development activities.\u003c\/p\u003e\n\n\u003cp\u003eFindings involving cellular or animal models should not be interpreted as evidence that the commercial NeuroClimax Advanced formulation restores neuronal function or treats neurological disease in humans.\u003c\/p\u003e\n\n\u003ch2\u003ePublished Preclinical Research\u003c\/h2\u003e\n\n\u003cp\u003eCNS Curative's scientific background includes published preclinical research investigating intranasal administration of forskolin and Noopept.\u003c\/p\u003e\n\n\u003ch3\u003eIntranasal Forskolin and Noopept Research\u003c\/h3\u003e\n\n\u003cp\u003eIn a published study, Dagda and colleagues investigated an experimental intranasal formulation containing forskolin and Noopept in a PINK1-knockout rat model of Parkinsonian pathology.\u003c\/p\u003e\n\n\u003cp\u003eThe study examined motor behavior, neuronal changes, and biological signaling pathways associated with protein kinase A, BDNF, and NGF.\u003c\/p\u003e\n\n\u003cp\u003eThe researchers reported experimental findings relevant to neuronal signaling and neurodegeneration in the animal model.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003ePublished reference:\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003cp\u003eDagda, R.K., Dagda, R.Y., Vazquez-Mayorga, E., Martinez, B., and Gallahue, A. \u003cem\u003eIntranasal Administration of Forskolin and Noopept Reverses Parkinsonian Pathology in PINK1 Knockout Rats.\u003c\/em\u003e International Journal of Molecular Sciences. 2023;24(1):690.\u003c\/p\u003e\n\n\u003cp\u003e\u003ca href=\"https:\/\/doi.org\/10.3390\/ijms24010690\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eRead the Published Scientific Study\u003c\/a\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eResearch limitation:\u003c\/strong\u003e This investigation involved experimental animals and a research formulation. Its findings do not establish the clinical safety, effectiveness, or therapeutic benefits of the finished commercial NeuroClimax Advanced product.\u003c\/p\u003e\n\n\u003ch2\u003eUnderstanding the Intranasal Delivery System\u003c\/h2\u003e\n\n\u003cp\u003eNeuroClimax Advanced uses a proprietary intranasal administration format.\u003c\/p\u003e\n\n\u003cp\u003eIntranasal delivery is an area of pharmaceutical research because the nasal cavity provides an alternative route for administering certain compounds.\u003c\/p\u003e\n\n\u003cp\u003eResearchers investigate intranasal delivery in relation to formulation properties, absorption, distribution, and potential applications involving the central nervous system.\u003c\/p\u003e\n\n\u003cp\u003eHowever, the performance of an intranasal product depends on its complete formulation and supporting product-specific evidence.\u003c\/p\u003e\n\n\u003cp\u003eThe administration route alone does not establish rapid absorption, direct brain delivery, improved bioavailability, or clinical effectiveness.\u003c\/p\u003e\n\n\u003ch2\u003eFormulation Components\u003c\/h2\u003e\n\n\u003ch3\u003ePrincipal Active Ingredients\u003c\/h3\u003e\n\n\u003cp\u003eAccording to CNS Curative's original product information, NeuroClimax Advanced includes:\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eForskolin and related cAMP-enhancing compounds:\u003c\/strong\u003e Investigated in research involving cyclic AMP signaling.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNoopept:\u003c\/strong\u003e Investigated in research involving neuronal and neurotrophic signaling.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThe company's original documentation also describes enhanced formulations that may contain \u003cstrong\u003ecentrophenoxine\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003cp\u003eThe inclusion and concentration of any additional active ingredient depend on the specific product formulation or batch and should be confirmed against current labeling.\u003c\/p\u003e\n\n\u003ch3\u003eInactive Ingredients and Excipients\u003c\/h3\u003e\n\n\u003cp\u003eThe original formulation information describes an excipient system intended to support solubility, stability, preservation, and intranasal administration.\u003c\/p\u003e\n\n\u003cp\u003eListed possible components include:\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003ePropylene glycol.\u003c\/li\u003e\n\u003cli\u003ePotassium or sodium sorbate.\u003c\/li\u003e\n\u003cli\u003eEDTA.\u003c\/li\u003e\n\u003cli\u003eGamma-cyclodextrins.\u003c\/li\u003e\n\u003cli\u003eSterile phosphate-buffered saline.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThese are components identified in the company's existing documentation and do not constitute a verified, complete ingredient declaration for every production batch.\u003c\/p\u003e\n\n\u003cp\u003eCustomers should consult the current product label or contact CNS Curative Technologies for exact ingredient concentrations and formulation specifications.\u003c\/p\u003e\n\n\u003ch2\u003eHow Does Advanced Compare with the NeuroClimax Gold Formulations?\u003c\/h2\u003e\n\n\u003cp\u003eThe NeuroClimax product family includes formulations with different active ingredients and scientific research backgrounds.\u003c\/p\u003e\n\n\u003ch3\u003eNeuroClimax Advanced\u003c\/h3\u003e\n\n\u003cp\u003e\u003cstrong\u003ePrincipal formulation focus:\u003c\/strong\u003e Forskolin, cAMP-enhancing compounds, and Noopept.\u003c\/p\u003e\n\n\u003cp\u003eDeveloped around compounds investigated in relation to cyclic AMP activity and neurotrophic signaling.\u003c\/p\u003e\n\n\u003ch3\u003eNeuroClimax Gold (Max)\u003c\/h3\u003e\n\n\u003cp\u003e\u003cstrong\u003eActive ingredients:\u003c\/strong\u003e Kinetin, Noopept, and centrophenoxine.\u003c\/p\u003e\n\n\u003cp\u003eCombines three compounds investigated in research involving mitochondrial biology, neuronal signaling, and cognitive processes.\u003c\/p\u003e\n\n\u003cp\u003e\u003ca href=\"\/products\/brain-health-support-against-brain-fog-and-brain-fatigue-with-neuroclimx-md\"\u003e\u003cstrong\u003eExplore NeuroClimax Gold (Max)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\n\u003ch3\u003eNeuroClimax Gold (Simple)\u003c\/h3\u003e\n\n\u003cp\u003e\u003cstrong\u003eActive ingredient:\u003c\/strong\u003e Kinetin.\u003c\/p\u003e\n\n\u003cp\u003eProvides a streamlined, single-active-ingredient formulation associated with research involving PINK1-related mitochondrial signaling.\u003c\/p\u003e\n\n\u003cp\u003e\u003ca href=\"\/products\/cognitive-enhancement-support-against-brain-fog-and-brain-fatigue-with-neuroclimx-gold-modified\"\u003e\u003cstrong\u003eExplore NeuroClimax Gold (Simple)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eImportant:\u003c\/strong\u003e These distinctions describe differences in ingredient composition and scientific background. They do not establish that one formulation is clinically superior, safer, or more effective than another.\u003c\/p\u003e\n\n\u003ch2\u003eManufacturing and Quality Information\u003c\/h2\u003e\n\n\u003cp\u003eNeuroClimax products are developed, manufactured, and distributed by \u003cstrong\u003eCNS Curative Technologies LLC\u003c\/strong\u003e, according to the company's published information.\u003c\/p\u003e\n\n\u003cp\u003eCNS Curative describes manufacturing processes involving controlled sterile cleanroom environments and quality-control procedures.\u003c\/p\u003e\n\n\u003cp\u003eThe company's original product documentation references cleanroom specifications associated with \u003cstrong\u003eISO 14644-1:2015\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003cp\u003eIt also describes quality-control testing involving selected parameters such as:\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eIngredient purity.\u003c\/li\u003e\n\u003cli\u003eFormulation integrity.\u003c\/li\u003e\n\u003cli\u003eMicrobiological contamination.\u003c\/li\u003e\n\u003cli\u003eSelected contaminants.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eSpecific facility classifications, certification status, batch testing, and sterility documentation should be verified against current supporting records.\u003c\/p\u003e\n\n\u003cp\u003eCustomers seeking detailed manufacturing or product-quality information can contact CNS Curative Technologies directly.\u003c\/p\u003e\n\n\u003ch2\u003ePatented Research and Intellectual Property\u003c\/h2\u003e\n\n\u003cp\u003eThe scientific and technological background associated with CNS Curative includes intellectual property involving the investigation of nootropic agents and neurological disorders.\u003c\/p\u003e\n\n\u003ch3\u003eU.S. Patent No. US11612583B2\u003c\/h3\u003e\n\n\u003cp\u003e\u003cstrong\u003ePatent title:\u003c\/strong\u003e Disease Modifying Methods for Treating Neurodegenerative Diseases Using Nootropic Agents.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eInventors:\u003c\/strong\u003e Raul Y. Dagda and Ruben K. Dagda.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eGrant date:\u003c\/strong\u003e March 28, 2023.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eRecorded assignee:\u003c\/strong\u003e Nevada Research \u0026amp; Innovation Corporation.\u003c\/p\u003e\n\n\u003cp\u003eThe patent describes methods involving nootropic compounds, including forskolin, in the context of neurological research and proposed therapeutic approaches.\u003c\/p\u003e\n\n\u003cp\u003eThe existence of a granted patent does not establish regulatory approval, clinical effectiveness, or authorization to market the finished NeuroClimax Advanced formulation for disease treatment.\u003c\/p\u003e\n\n\u003cp\u003e\u003ca href=\"https:\/\/patents.google.com\/patent\/US11612583B2\/en\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eReview the U.S. Patent Record\u003c\/a\u003e\u003c\/p\u003e\n\n\u003cp\u003eCNS Curative's original documentation also references a U.S. patent option agreement identified as \u003cstrong\u003eNVRIC-OPTN-25-CNSCurative\u003c\/strong\u003e. The current status and scope of that agreement should be confirmed with the company.\u003c\/p\u003e\n\n\u003ch2\u003eNational Science Foundation I-Corps Customer Discovery\u003c\/h2\u003e\n\n\u003cp\u003eAccording to CNS Curative's original product information, the company participated in customer-discovery activities supported through the \u003cstrong\u003eNational Science Foundation I-Corps program\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003cp\u003eThe reported activities involved discussions with prospective users, patients, caregivers, healthcare stakeholders, and other relevant groups.\u003c\/p\u003e\n\n\u003cp\u003eAreas explored included:\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eUnmet needs involving neurological and cognitive health.\u003c\/li\u003e\n\u003cli\u003ePatient and caregiver priorities.\u003c\/li\u003e\n\u003cli\u003eChallenges associated with existing approaches.\u003c\/li\u003e\n\u003cli\u003ePreferences regarding product delivery and usability.\u003c\/li\u003e\n\u003cli\u003ePotential applications of the underlying technology.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eCustomer-discovery activities provide commercial and development insights. They do not constitute independent clinical validation, regulatory approval, or an endorsement of the finished product by the National Science Foundation.\u003c\/p\u003e\n\n\u003ch2\u003eBefore Ordering NeuroClimax Advanced\u003c\/h2\u003e\n\n\u003cp\u003eReview the product's current labeling, active and inactive ingredients, directions, warnings, and purchasing terms before making a decision.\u003c\/p\u003e\n\n\u003cp\u003eIf you have questions about the formulation, ingredient concentrations, manufacturing information, product suitability, or supporting scientific documentation, contact CNS Curative Technologies.\u003c\/p\u003e\n\n\u003cp\u003eSeek advice from an appropriately qualified healthcare professional regarding individual medical considerations.\u003c\/p\u003e\n\n\u003cp\u003eCurrent pricing, availability, and purchasing options are displayed separately on this product page.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eHelpful customer information:\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"\/pages\/contact\"\u003eContact CNS Curative Technologies\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/policies\/shipping-policy\"\u003eShipping Information\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/policies\/refund-policy\"\u003eReturns and Refund Information\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eAbout CNS Curative Technologies\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eCNS Curative Technologies LLC\u003c\/strong\u003e\u003cbr\u003e\n300 East 2nd Street\u003cbr\u003e\n15th Floor, Suite 1512\u003cbr\u003e\nReno, Nevada 89501\u003cbr\u003e\nUSA\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCompany website:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.cnscurative.com\/\" target=\"_blank\" rel=\"noopener noreferrer\"\u003ewww.cnscurative.com\u003c\/a\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eOnline store:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.cnscurative.store\/\"\u003ewww.cnscurative.store\u003c\/a\u003e\u003c\/p\u003e\n\n\u003ch2\u003eImportant Scientific and Safety Information\u003c\/h2\u003e\n\n\u003cp\u003e\u003cem\u003eThe scientific information presented on this page includes published mechanistic and preclinical research involving individual compounds and experimental formulations.\u003c\/em\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003cem\u003eFindings obtained from laboratory studies and animal models do not establish the clinical safety, effectiveness, appropriate dosing, or therapeutic benefits of the finished NeuroClimax Advanced product in humans.\u003c\/em\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003cem\u003eProduct-specific regulatory status, labeling, ingredient specifications, safety information, and marketing claims should be reviewed and approved by CNS Curative Technologies and appropriately qualified regulatory professionals.\u003c\/em\u003e\u003c\/p\u003e","brand":"My Store","offers":[{"title":"Default Title","offer_id":45347825254549,"sku":"CNS002","price":85.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0671\/3167\/0677\/files\/82b68abf-ff36-4f31-9667-1daee4e5103b.jpg?v=1791945717","url":"https:\/\/www.cnscurative.store\/products\/neuroclimax-advanced","provider":"CNS Curative Store","version":"1.0","type":"link"}